Stroke outcomes
Stroke program
|
How we compare* |
CHOMP |
GWTG
ALL Hospitals |
GWTG
CA** Hospitals |
Higher is better (Full Year 2018 Data)
|
|
Door to tPA in 60 minutes
Percent of acute ischemic stroke patients receiving intravenous tissue plasminogen activator (tPA) therapy during the hospital stay who have a time from hospital arrival to initiation of thrombolytic therapy administration (door-to-needle time) of 60 minutes or less.
(Two million brain cells die every minute during an acute stroke. The more rapidly tPA – a clot-busting medication – is given, the better the patient outcomes). |
 |
95% |
83% |
87% |
Door to tPA in 45 minutes
Percent of acute ischemic stroke patients receiving intravenous tissue plasminogen activator (tPA) therapy during the hospital stay who have a time from hospital arrival to initiation of thrombolytic therapy administration (door-to-needle time) of 45 minutes or less.
(Two million brain cells die every minute during an acute stroke. The more rapidly tPA – a clot-busting medication – is given, the better the patient outcomes). |
|
44% |
43% |
47% |
Lower is better (Full Year 2018 Data)
|
|
tPA complication rate
Complications include: bleeding into the brain and/or other serious bleeding risks (e.g., gastrointestinal).
|
|
3% |
4% |
4% |
Data is shown for ischemic stroke, a stroke caused by arteries to the brain being narrowed or blocked which results in reduced blood flow. If this continues, even for a few minutes, brain cells start to die.
*As compared to ALL (nationwide) hospitals in the American Heart/Stroke Association Get with the Guidelines (GWTG) Database. GWTG is a program that ensures continuous quality improvement of acute stroke treatment and ischemic stroke prevention. The program aims to help ensure that eligible patients are initiated on guideline-recommended therapies and receive appropriate counseling prior to hospital discharge.
**California (CA) Hospitals in the American Heart/Stroke Association Get with the Guidelines Database (GWTG).
